Gut microbiota in celiac disease.

Area of Science:

• Immunology
• Gastroenterology
• Microbiology

Background:

• Celiac disease (CD) is an autoimmune gastrointestinal disorder triggered by gluten in genetically susceptible individuals.
• A strict gluten-free diet is the only current treatment, but adjuvant therapies are increasingly needed due to rising CD prevalence.
• The pathogenesis of CD involves a complex interplay of genetic predisposition, environmental factors, immune responses, and the gut microbiota.

Purpose of the Study:

• To review the critical role of gut microbiota in the pathogenesis of celiac disease.
• To highlight the symbiotic relationship between the host and its gut microbial flora.
• To introduce factors influencing early intestinal flora development and their connection to CD.

Main Methods:

• This mini-review synthesizes current research on the gut microbiome and celiac disease.
• It examines the influence of early life microbial colonization on immune development.
• The review discusses the mechanisms by which gut microbiota may contribute to CD pathogenesis.

Main Results:

• Emerging evidence points to the gut microbiota as a significant factor in autoimmune conditions, including CD.
• Alterations in gut microbial composition and function are increasingly implicated in CD development and progression.
• Understanding the gut microbiome's role offers potential avenues for novel therapeutic strategies.

Conclusions:

• The gut microbiota plays a crucial role in the immune system's interaction with dietary gluten, influencing celiac disease development.
• Further research into the gut microbiome's symbiotic relationship with the host is essential for developing effective adjuvant therapies for CD.
• Targeting the gut microbiota may represent a promising future strategy for managing celiac disease.